Premium
MabCure Inc (CE) (MBCI)
USOTC
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
MabCure Inc., (OTCBB:MBCI) a leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers today announced it...
MabCure, Inc. (OTCBB:MBCI), a leading developer of antibody based diagnostics and treatments for ovarian, prostate and other cancers today announced that it has recently...
MabCure, Inc. (OTCBB: MBCI), a leading developer of antibody-based diagnostics and treatments for ovarian and prostate cancer, today announced that it has signed a license...
Biotechnology company MabCure, Inc. (OTCBB: MBCI) is presenting the results of its recently completed study on the diagnosis of ovarian cancer utilizing its proprietary...
MabCure Inc. (OTCBB:MBCI) We are pleased to provide this update on recent important developments and on our progress in several key areas, including our ovarian cancer...
Biotechnology company MabCure, Inc. (OTCBB: MBCI) today announced the signing of a $10,000,000 Equity Funding Facility with Centurion Private Equity, LLC (“Centurion”), an...
Biotechnology company MabCure, Inc. (OTCBB: MBCI) today announced that it has appointed Dr. Charles T. Tackney as its new Chief Scientific Officer. Dr. Tackney is a...
Biotechnology company MabCure, Inc. (OTCBB: MBCI) today announced that it has generated a panel of 10 novel monoclonal antibodies (MAbs) against prostate cancer. These MAbs were...
Biotechnology company MabCure, Inc. (OTCBB: MBCI) today announced that it has signed a collaboration agreement with Catholic University, K.U. Leuven and University Hospital, UZ...
Biotechnology company MabCure, Inc. (OTCBB: MBCI) today announced the company has filed a provisional patent application for its ovarian cancer diagnostic antibodies with the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1000 | 1.0E-6 | CS |
| 26 | -3.0E-6 | -75 | 4.0E-6 | 0.0001 | 1.0E-6 | 5261 | 7.773E-5 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.001112 | 1.0E-6 | 6585 | 3.677E-5 | CS |
| 156 | -0.007549 | -99.9867549669 | 0.00755 | 0.009 | 1.0E-6 | 8428 | 0.00322393 | CS |
| 260 | -0.000599 | -99.8333333333 | 0.0006 | 0.0189 | 1.0E-6 | 49423 | 0.00436187 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
